BAXTER Healthcare, which is planning to buy a unit of Adcock Ingram, has completed its due diligence of Adcock Ingram's Critical Care (AICC) division. The two companies are now in the process of finalising the shareholders' agreement. They have also begun discussions regarding the basis for determining the fair market value of AICC as set out in the option agreement. Baxter, a Swiss firm, notified Adcock of its intention to exercise a call option to acquire 51 percent of AICC last year.

Slindile Khanyile: Business Report, 10 May 2010